Kodiak Sciences Inc
General ticker "KOD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $417.2M
Kodiak Sciences Inc follows the US Stock Market performance with the rate: 18.7%.
Estimated limits based on current volatility of 4.8%: low 8.39$, high 9.23$
Factors to consider:
- Current price 84.8% above estimated high
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.77$, 5.01$]
- 2024-12-30 to 2025-12-30 estimated range: [1.56$, 4.32$]
Financial Metrics affecting the KOD estimates:
- Negative: Non-GAAP EPS, $ of -4.96 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -50.91 <= 2.35
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term KOD quotes
Long-term KOD plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $267.05MM | $341.38MM | $277.32MM |
| Operating Income | $-267.05MM | $-341.38MM | $-277.32MM |
| Non-Operating Income | $0.06MM | $7.56MM | $16.83MM |
| Interest Expense | $0.02MM | $0.02MM | $0.01MM |
| R&D Expense | $217.34MM | $267.59MM | $206.30MM |
| Income(Loss) | $-266.99MM | $-333.82MM | $-260.49MM |
| Profit(Loss) | $-266.99MM | $-333.82MM | $-260.49MM |
| Stockholders Equity | $663.32MM | $436.17MM | $265.78MM |
| Assets | $904.22MM | $666.63MM | $479.37MM |
| Operating Cash Flow | $-182.27MM | $-206.46MM | $-154.18MM |
| Capital expenditure | $63.30MM | $47.36MM | $41.43MM |
| Investing Cash Flow | $-38.80MM | $-336.51MM | $249.23MM |
| Financing Cash Flow | $0.01MM | $0.00MM | $0.03MM |
| Earnings Per Share* | $-5.16 | $-6.39 | $-4.97 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.